Shweta Lavania
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 4
- Cancer Cells and Metastasis 4
-
- Phagocytosis and Immune Regulation 2
- Immune cells in cancer 2
-
- Cancer Genomics and Diagnostics 2
-
- Gut microbiota and health 3
-
- Cancer Research and Treatments 2
-
- Natural Compounds in Disease Treatment 2
- Co-authors
- Sulagna BanerjeeAshok K. SalujaVikas DudejaVrishketan SethiBhuwan GiriSelwyn M. VickersRajinder DawraBharti Garg
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United StatesIndiaSouth Korea
In The Last Decade
Shweta Lavania
14 papers receiving 613 citations
Peers
Comparison fields: 5 of 71
- Oncology 379
- Immunology 128
- Cancer Research 80
- Molecular Biology 356
- Biotechnology 35
Countries citing papers authored by Shweta Lavania
This map shows the geographic impact of Shweta Lavania's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shweta Lavania with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shweta Lavania more than expected).
Fields of papers citing papers by Shweta Lavania
This network shows the impact of papers produced by Shweta Lavania. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shweta Lavania. The network helps show where Shweta Lavania may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shweta Lavania, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2023 | 12 | |
| 3 | 2022 | 18 | |
| 4 | 2022 | 17 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 12 | |
| 7 | 2021 | 3 | |
| 8 | 2020 | 53 | |
| 9 | 2019 | 28 | |
| 10 | 2018 | 130 | |
| 11 | 2018 | 301 | |
| 12 | 2018 | 2 | |
| 13 | 2018 | 1 | |
| 14 | 2015 | 32 |
About Shweta Lavania
Shweta Lavania is a scholar working on Oncology, Complementary and alternative medicine and Biotechnology, having authored 14 papers that have together received 619 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (4 papers), Cancer Cells and Metastasis (4 papers), Gut microbiota and health (3 papers), Natural Compounds in Disease Treatment (2 papers), Cancer Research and Treatments (2 papers), Phagocytosis and Immune Regulation (2 papers), Immune cells in cancer (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (379 citations), Immunology (128 citations) and Cancer Research (80 citations). Shweta Lavania has collaborated with scholars based in United States, India and South Korea. Frequent co-authors include Sulagna Banerjee, Ashok K. Saluja, Vikas Dudeja, Vrishketan Sethi, Bhuwan Giri, Selwyn M. Vickers, Rajinder Dawra, Bharti Garg, Sundaram Ramakrishnan and Anthony Ferrantella. Their work appears in journals such as Gastroenterology, Cancer Research and Journal of Cell Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.